Biomatrix (BXM) Looking Great Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biomatrix (BXM) Looking Great

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: James Baker who wrote (80)	9/9/1997 6:27:00 AM
From: John McCarthy	of 569

James - One clarification. The IBD article suggested the following: The DISTRIBUTORS may sell it for $495 a treatment. (I don't know if that means per needle - or 3 needles worth) BIOX take would be $30.00 (dollars) per needle. FYI: I am not totally sure of this, because I lost my source. The deal they have with Collagen goes something like this: The entire market (WW) for this skin care is $60 million. The part of the market that needs BIOX product is ONLY 5% of the $60 million market. Not much $. Here's the kicker: BIOX gets a piece of the whole $60 million. You might ask why would Collagen (sp?) do this. My guess: ( all speculation ) No skin test is required with the BIOX product. (FACT) You just put it in. The existing products REQUIRE a skin test. Alot of people like me are gettin old. The BIOX product changes the overall size of the potential market for Collagen because it is hassle free. The product produces good results. Regards, John McCarthy

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next